Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Moolec Science's share price for the quarter that ended in Dec. 2025 was $3.818999. Moolec Science's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 0.7 Mil. Therefore, Moolec Science's market cap for the quarter that ended in Dec. 2025 was $2.8 Mil.
Moolec Science's quarterly market cap
increased
from Dec. 2024 ($32.0 Mil) to Jun. 2025 ($68.6 Mil) but then
declined
from Jun. 2025 ($68.6 Mil) to Dec. 2025 ($2.8 Mil).
Moolec Science's annual market cap
declined
from Jun. 2023 ($138.0 Mil) to Jun. 2024 ($42.1 Mil) but then
increased
from Jun. 2024 ($42.1 Mil) to Jun. 2025 ($68.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Moolec Science's Enterprise Value for Today is $76.9 Mil.
Moolec Science (NAS:MLEC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Moolec Science Market Cap Related Terms
Moolec Science Market Cap Historical Data
* Premium members only.
The historical data trend for Moolec Science's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Moolec Science's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moolec Science Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moolec Science's Market Cap distribution charts can be found below:
* The bar in red indicates where Moolec Science's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Moolec Science's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moolec Science (MLEC) has a Market Cap of $5.5 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Moolec Science and its competitors. According to the industry distribution chart, Moolec Science ranks #1285 out of 1430 companies in the Biotechnology industry, placing it in the top 89.9%.
Is Moolec Science's Market Cap too high?
Moolec Science's current Market Cap is $5.5 Mil. The Biotechnology industry median Market Cap is 117.26. Moolec Science's value of $5.5 Mil is 95.3% below this industry median. Based on the distribution chart, Moolec Science ranks #1285 out of 1430 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Moolec Science has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's Market Cap compare to RVPH and CDIO?
According to the Biotechnology industry distribution chart, Moolec Science ranks #1285 out of 1430 companies for Market Cap. This places Moolec Science in the lower half of its industry. The industry median Market Cap is 117.26. Moolec Science's value of $5.5 Mil is 95.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.26, based on 1,430 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Moolec Science's current Market Cap of $5.5 Mil is 95.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Moolec Science and its competitors. For the Biotechnology industry, the median Market Cap is 117.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moolec Science's current Market Cap is $5.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $7.62 — trading 91% below its estimated fair value. The current Market Cap is $5.5 Mil and 95.3% below the Biotechnology industry median of 117.26. Moolec Science's overall GF Score™ is 46/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Moolec Science (MLEC), the current Market Cap is $5.5 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moolec Science (MLEC) Overvalued in 2026?
Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued.
The current stock price of $7.62 is trading 91% below its estimated GF Value™ of $84.84.
GuruFocus considers Moolec Science to be Possible Value Trap.
Key valuation signals for MLEC:
Market Cap: $5.5 Mil
GF Value™: $84.84 vs. price of $7.62 (91% below fair value)
Industry Position: 95.3% below the Biotechnology median (#1285 of 1430)
No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
46GF Score
Get the complete analysis for MLEC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLEC has been successfully added to your 
